Episodes: 35
Frequency: Irregular
Rating: 4.7/5.0
Estimated listeners: 100 - 1,000
Gender skew: Female
Listener location: USA
YouTube: 1.7k subscribers
Instagram: 1.1k followers
Publicly listed emails
mary.gaulke@porternovelli.com
Looking for the right person? Join Podseeker to find direct host and producer contacts and manage your podcast outreach.
Susanna Quinn - Host Susanna Quinn explores topics relating to early cancer detection testing, including multi-cancer early detection testing, cancer genomics and risk, and barriers to cancer screening.
Robert - Experience As A Trial Participant After A Cancer Signal Detected Result; Diagnostic Follow-up; Biopsy Finding; Emotional/physical Impact; Value Of Earlier Detection
Dr. Robert Merritt - Diagnosing And Treating Kevin After An MCED Signal; Role Of Early Detection For Prognosis And Recovery
Kevin McFarland - How An MCED Result Led To Further Exams And Diagnosis Of Esophageal Cancer; Emotional/mental/physical Impact; Importance Of Early Detection; Accessibility And Advocacy
Nima Nabavizadeh, MD - PATHFINDER 2 Study Results From ESMO 2025; Safety And Performance Of The Galleri MCED Test; Significance For Patients And Potential Impact On Early Cancer Detection
34 - When Bile Duct Cancer is Found at Stage 1A: Melissa's Story
September 09, 2026
Melissa was healthy, had no worrisome symptoms, and never expected cancer to become part of her story. But after making the Galleri multi-cancer early detection (MCED) test part of her health routine, her second annual test returned a Cancer Signal Detected result with a predicted origin of liver/bile ducts. On this episode of The Cancer SIGNAL podcast, Melissa shares what happened next, including the diagnostic journey that would confirm her Stage IA cancer diagnosis. Melissa also reflects o...
33 - Roger: A Pancreatic Cancer Survivor Story
August 03, 2026
Host Rayshawnda Madison connects with Roger, a returning guest who first shared his story in 2023 after receiving a Cancer Signal Detected result from the Galleri multi-cancer early detection (MCED) test. Follow-up testing led to a stage II pancreatic cancer diagnosis. Now, three years later, Roger reflects on how life has evolved since completing treatment, what survivorship looks like for him today, and the mindset that helped him move forward. He also shares how the experience changed his ...
32 - NHS-Galleri Trial: One Participant's Journey Through Early Detection
June 01, 2026
In this episode, Robert, a carpenter from the Midlands in England and a participant in the NHS-Galleri trial, joins host Shawnda Madison to share his experience. After enrolling in the trial, Robert received a Cancer Signal Detected result from the Galleri multi-cancer early detection (MCED) test despite having no symptoms. The initial diagnostic evaluation did not identify cancer, but a subsequent Galleri test the following year returned the same result, leading his care team to continue inv...
The Cancer SIGNAL is hosted by Susanna Quinn. Its publicly listed email is mary.gaulke@porternovelli.com. For guest bookings, the host or producer is usually the best person to reach. Podseeker helps you find direct host and producer contacts and pitch from your own inbox.
The publicly listed email for The Cancer SIGNAL: mary.gaulke@porternovelli.com.
Podseeker estimates The Cancer SIGNAL reaches 100 to 1,000 listeners per episode. Only the publisher has exact numbers.
The Cancer SIGNAL typically books industry leaders. Typical guest background: Clinical researchers and senior oncology/radiation medicine/early detection investigators (often principal investigators of MCED/early detection trials); thoracic/oncology clinicians who have diagnosed/treated patients identified via MCED; patient voices with direct experience as MCED trial participants or patients whose follow-up confirmed cancer. Common among recent guests: Principal investigator or key investigator on MCED/early detection trials; Published conference findings (e.g., presented at major oncology congresses); Clinical leadership in diagnosing and treating cancers identified through screening tests. Recent guests include Robert, Dr. Robert Merritt, and Kevin McFarland.
Medium. Guests usually need solid credentials in the topic and an idea that fits the show.
Recent episodes cover Oncology, Cancer Screening, Diagnostics, Clinical Trials, and Genomics. Pitch an idea tied to one of these topics and mention a recent episode.
Publicly listed emails
mary.gaulke@porternovelli.com
Looking for the right person? Join Podseeker to find direct host and producer contacts and manage your podcast outreach.
Try us risk free with a FREE 3 days trial.
Join hundreds of PR teams using Podseeker to pitch and land bookings